Melissa Lim
Impact in
- Rheumatology top 10%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
-
- Psoriasis: Treatment and Pathogenesis
- Galectins and Cancer Biology
Papers in
-
- Signaling Pathways in Disease 1
- Oncology 6
- Peptidase Inhibition and Analysis 3
- Co-authors
- Zoya Qaiyum (6 shared papers)Carol Basbaum (2 shared papers)David M. Jablons (2 shared papers)Jiandong Li (1 shared paper)Huiming Guo (1 shared paper)R. A. Cameron (1 shared paper)Bryan P. Toole (1 shared paper)Robert D. Inman (4 shared papers)
- Journals
- Journal of Clinical Investigation (4 papers)iScience (1 paper)Biomolecules (1 paper)FEBS Letters (1 paper)Lung Cancer (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Melissa Lim
12 papers receiving 398 citations
Peers
Comparison fields: 5 of 61
- Rheumatology 111
- Immunology 146
- Cancer Research 83
- Hematology 60
- Oncology 115
Countries citing papers authored by Melissa Lim
This map shows the geographic impact of Melissa Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Lim more than expected).
Fields of papers citing papers by Melissa Lim
This network shows the impact of papers produced by Melissa Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Lim. The network helps show where Melissa Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Melissa Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 140 | |
| 2 | 2020 | 54 | |
| 3 | 2019 | 44 | |
| 4 | 2017 | 36 | |
| 5 | 2017 | 33 | |
| 6 | 2021 | 31 | |
| 7 | 2023 | 30 | |
| 8 | 1995 | 17 | |
| 9 | 2022 | 6 | |
| 10 | 2003 | 6 | |
| 11 | 2025 | 5 | |
| 12 | 1973 | 2 | |
| 13 | 2024 | 0 | |
| 14 | 2025 | 0 |
About Melissa Lim
Melissa Lim is a scholar working on Molecular Biology, Oncology, Rheumatology, Hematology and Immunology, having authored 14 papers that have together received 404 indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (6 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Peptidase Inhibition and Analysis (3 papers), Protease and Inhibitor Mechanisms (2 papers), Systemic Lupus Erythematosus Research (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper), Signaling Pathways in Disease (1 paper) and Medical Imaging and Pathology Studies (1 paper). The work is most often cited by research in Rheumatology (111 citations), Immunology (146 citations), Cancer Research (83 citations), Hematology (60 citations) and Oncology (115 citations). Melissa Lim has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Zoya Qaiyum, Carol Basbaum, David M. Jablons, Jiandong Li, Huiming Guo, R. A. Cameron, Bryan P. Toole, Robert D. Inman, Eric Gracey and Michael Tang. Their work appears in journals such as Journal of Clinical Investigation, iScience, Biomolecules, FEBS Letters and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.